Key result
Surgical revascularization shows no 1-year quality-of-life benefit over endovascular therapy.
Why the study?
Despite efforts to promote limb salvage in chronic limb-threatening ischemia (CLTI), the factors associated with meaningful health status improvement after endovascular or surgical revascularization remain poorly understood.
Does surgical versus endovascular revascularization and baseline patient factors predict clinically meaningful 1-year health status improvements in patients with chronic limb-threatening ischemia?
RCT (n=1,017)
Randomized
Yes
Does surgical versus endovascular revascularization and baseline patient factors predict clinically meaningful 1-year health status improvements in patients with chronic limb-threatening ischemia?
Answers are grounded in this paper and cite their sources.
Over three-fourths of patients with chronic limb-threatening ischemia experience clinically meaningful PAD-specific health status improvements 1 year after revascularization regardless of whether an endovascular or surgical approach is used, though cardiometabolic risk factors and higher baseline health status predict lack of improvement.
Background Despite efforts to promote limb salvage in chronic limb‐threatening ischemia (CLTI), the factors associated with meaningful health status improvement after revascularization remain poorly understood. We examined predictors of meaningful 1‐year health status improvement following revascularization for CLTI. Methods We pooled endovascular and surgical arms from the BEST‐CLI (Best Endovascular Versus Best Surgical Therapy in Patients With CLTI) randomized controlled trial, including patients with CLTI (150 international sites, 2014–2019). Health status was assessed at baseline and 1 year using the peripheral artery disease‐specific Vascular Quality of Life questionnaire, the generic European Quality‐of‐Life 5 Dimensions, and the Short Form‐12 Physical and Mental Component Summary. Distribution‐based minimal clinically important difference thresholds were defined as 0.5 SD of baseline health status scores. Multivariable logistic regression identified predictors of no meaningful 1‐year improvement (same/worsened versus improved). Results Among 1017 patients (72.0% men, mean age 66.8±9.7 years), clinically meaningful improvements were reported by 76.5% for Vascular Quality of Life, 52.8% European Quality‐of‐Life 5 Dimensions, 56.7% for Short Form‐12 Physical Component Summary, and 42.1% for Short Form‐12 Mental Component Summary, regardless of revascularization type (surgical versus endovascular). Cardiometabolic risk factors and higher preprocedural health status increased the odds of no meaningful improvement. Revascularization type was not associated with Vascular Quality of Life improvement (odds ratio, 1.059 [95% CI, 0.91–1.23]; P =0.445; C statistic=0.77). Conclusions One‐year postrevascularization, over three‐fourths of individuals with CLTI perceived meaningful improvements in peripheral artery disease‐specific health, and over half improved overall physical health, regardless of procedure type. Cardiometabolic risk factors and higher preprocedural health status predicted 1‐year health status response. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT02060630
No takes yet. Share an insight, caveat, or question.
Smolderen et al. (2026) conducted an RCT in Chronic limb-threatening ischemia (CLTI) (n=1,017). Surgical revascularization vs. Endovascular revascularization was evaluated on Clinically meaningful 1-year improvement in Vascular Quality of Life questionnaire (OR 1.059, 95% CI 0.91-1.23, p=0.445). Revascularization type (surgical vs endovascular) was not associated with 1-year Vascular Quality of Life improvement, with 76.5% improving overall.
Synapse has enriched 10 related papers. Consider them for comparative context: